Johnson & Johnson MedTech will build a 200,000-sf² manufacturing facility in Alajuela, Costa Rica, the medical device developer said today.
It’s the largest investment J&J MedTech has ever made outside the U.S., according to Procomer, the agency that promotes Costa Rican exports.
J&J MedTech — Johnson & Johnson’s medical device business — said the plant will manufacture products across its franchises, with an emphasis on heart rhythm solutions and orthopedics. The new plant will also have space for shared services and will assess and support demand for product across J&J MedTech’s portfolio, which includes DePuy Synthes, Biosense Webster, Cerenovus, Ethicon and Johnson & Johnson Vision.
Construction starts this year on the facility, which will add around 3,000 new jobs in the region over the next three to five years, the company said.
“Nearly 300 million patients are treated with Johnson & Johnson MedT…